Detalhe da pesquisa
1.
3D chromatin remodeling potentiates transcriptional programs driving cell invasion.
Proc Natl Acad Sci U S A;
119(36): e2203452119, 2022 09 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36037342
2.
POGZ promotes homology-directed DNA repair in an HP1-dependent manner.
EMBO Rep;
23(1): e51041, 2022 01 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34758190
3.
Single base-pair resolution analysis of DNA binding motif with MoMotif reveals an oncogenic function of CTCF zinc-finger 1 mutation.
Nucleic Acids Res;
50(15): 8441-8458, 2022 08 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35947648
4.
Achieving clinical success with BET inhibitors as anti-cancer agents.
Br J Cancer;
124(9): 1478-1490, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33723398
5.
HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
J Virol;
92(20)2018 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30068653
6.
Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide.
Nucleic Acids Res;
45(20): 11941-11953, 2017 Nov 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28981728
7.
Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.
Proc Natl Acad Sci U S A;
112(7): E677-86, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25646466
8.
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential.
Biochim Biophys Acta;
1865(2): 275-88, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27085853
9.
Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.
Mol Cell;
34(3): 271-84, 2009 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19450526
10.
Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors.
BMC Med;
13: 217, 2015 Sep 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26354718
11.
MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors.
iScience;
27(3): 109188, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38433910
12.
Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition.
Mol Cancer Ther;
20(1): 64-75, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33087508
13.
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.
JCI Insight;
6(4)2021 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33470989
14.
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles.
Blood Adv;
5(6): 1682-1694, 2021 03 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33720339
15.
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Nat Commun;
12(1): 3299, 2021 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34083537
16.
Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter.
Nucleic Acids Res;
36(2): 435-43, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18039708
17.
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.
Blood Adv;
4(17): 4124-4135, 2020 09 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32882003
18.
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.
Clin Cancer Res;
26(15): 3908-3917, 2020 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32156746
19.
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming.
Cell Metab;
31(2): 250-266.e9, 2020 02 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32023446
20.
Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Expert Opin Ther Targets;
23(7): 565-578, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31177918